Sandoz’ commitment to patients

As a global leader in biosimilars, Sandoz is committed to pioneer access for patients by bringing, high-quality, more affordable, potentially life-changing biologic treatments across oncology, immunology, endocrinology and underserved disease areas, to countries worldwide.

Sandoz is working with stakeholders to break down barriers of access to treatments for patients.

Sandoz is the generics and biosimilars division of Novartis.
For more information: https://www.sandoz.com/products-services/biopharmaceuticals

Watch the full “Biosimilars and Sandoz” video here: https://youtu.be/o91j8lB7jy4

Видео Sandoz’ commitment to patients канала Sandoz